RIC alloBMT With Post-transplant Cyclophosphamide for Refractory Systemic Sclerosis
Clinical trial NCT05298358 · TERMINATED
Trial details
- NCT number
- NCT05298358
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-18
- Primary completion
- 2024-11-13
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.